A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product

Part of paid clinical trials in Gilbert, Arizona.

Sponsor
Century Therapeutics, Inc.
Study ID
NCT05768269
Status
Recruiting

Conditions

  • Hematological Malignancy
  • Solid Tumor Malignancy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • No Intervention — OTHER
    As this is a non-interventional rollover, long-term safety follow-up study, no intervention will be administered.

Study Details

This study is designed to collect long-term safety and survival data from participants previously treated in an eligible Century-sponsored index trial. This is an observational study, and the elements of the study design allow for important follow-up for safety, survival, and the continued evaluation of any late adverse events (AEs) that may appear after treatment with such cellular products. Additionally, collection of persistence data from participants will support the identification of any long-term risks or late AEs that may be causally related to treatment with such cellular products.

Key Dates

Start date
Apr 29, 2024
Status verified
Jun 2025
Primary completion
Mar 31, 2040
Completion
Mar 31, 2040

Study Design

Enrollment
375 participants (estimated)

Arms

  • Arm: Cellular Therapy
    Participants who have previously received an induced pluripotent stem cell (iPSC)-derived, ex vivo genome edited cellular therapy product in an eligible Century-sponsored index trial will be enrolled in this study for up to 180 months following the last treatment with a cellular therapy product in an eligible index trial.

Primary Outcome Measure

Number of Participants With any Adverse Events of Special Interest (AESI) [ Time Frame: Up to 180 months ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Banner MD Anderson Cancer CenterGilbertArizona85234
Dr Matthew Ulrickson
480-256-6444
University of Southern California - Norris Comprehensive Cancer CenterLos AngelesCalifornia90033
Dr Yaghmour
323-865-3170
University of Maryland Medical CenterBaltimoreMaryland21201
Dr Nancy Hardy
410-328-1230
Corewell HealthGrand RapidsMichigan49503
Dr Sami Brake
616-486-5933
Levine Cancer InstituteCharlotteNorth Carolina28204
Dr Moyo
980-442-2301
University of Cincinnati Medical CenterCincinnatiOhio45229
Dr Latif
513-584-7824
Swedish Cancer InstituteSeattleWashington98104
Dr. Krish Patel
206-991-2040

Find similar trials in Gilbert, AZ

Related Studies